What laboratory tests are recommended for a patient presenting with encephalopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Encephalopathy

All patients presenting with encephalopathy require a comprehensive metabolic panel, complete blood count, blood cultures, urinalysis with culture, liver function tests, and blood glucose as first-tier essential tests, with additional targeted testing based on clinical context and suspected etiology. 1

Essential First-Tier Laboratory Tests (Obtain in All Patients)

Core Metabolic and Hematologic Studies

  • Complete metabolic panel including sodium, potassium, chloride, bicarbonate, blood urea nitrogen, and creatinine to identify electrolyte disturbances and renal dysfunction 1
  • Blood glucose measurement to detect hypoglycemia or hyperglycemia 1
  • Serum calcium and magnesium levels, as disturbances commonly contribute to altered mental status 1
  • Complete blood count with differential to assess for infection or hematologic abnormalities 1
  • Liver function tests including transaminases, bilirubin, albumin, and INR to evaluate for hepatic encephalopathy 1

Infection Screening

  • Blood cultures (at least two sets) to identify bacteremia 2
  • Urinalysis with culture to detect urinary tract infection 2
  • Chest imaging (chest X-ray or CT) to identify pneumonia 2

Additional Baseline Studies

  • Thyroid-stimulating hormone (TSH) to exclude hypo- or hyperthyroidism 1
  • Blood alcohol level and toxicology screen to identify toxic causes 1

Cerebrospinal Fluid Analysis (When Indicated)

Lumbar puncture should be performed when infectious or autoimmune encephalitis cannot be excluded clinically, after neuroimaging excludes mass effect. 2, 3

Standard CSF Studies

  • Opening pressure measurement 2
  • Cell count with differential (WBC, RBC) 2
  • Protein and glucose (with simultaneous serum glucose) 2
  • Gram stain and bacterial culture 2

Infectious Workup

  • HSV-1/2 PCR (consider HSV CSF IgG and IgM if PCR not immediately available) 2
  • VZV PCR (consider VZV CSF IgG and IgM as sensitivity may be low) 2
  • Enterovirus PCR 2
  • Cryptococcal antigen and/or India Ink staining 2
  • VDRL for neurosyphilis 2

Autoimmune Studies

  • Oligoclonal bands and IgG index 2

Collect at least 20 cc of CSF if possible and freeze 5-10 cc for additional testing. 2

Serum Studies for Specific Etiologies

Infectious Causes

  • HIV serology (consider RNA testing) 2
  • Treponemal testing (RPR and specific treponemal test) 2
  • Hold acute serum and collect convalescent serum 10-14 days later for paired antibody testing 2

Autoimmune Encephalitis (Based on Clinical Features)

  • Anti-NMDAR antibody (serum and CSF) if psychotic features or movement disorder present 2
  • Autoimmune limbic encephalitis panel if prominent limbic symptoms 2
  • Anti-VGKC antibody (serum) if hyponatremia present 2

Nutritional Deficiencies

  • Vitamin B12 and folate levels, especially in patients with alcohol use disorder or malnutrition 1
  • Thiamine deficiency assessment should be considered, though treatment should not be delayed for test results in at-risk patients 1

Context-Specific Testing

Immunocompromised Patients

  • CMV PCR, HHV6/7 PCR, HIV PCR (CSF) 2
  • Toxoplasma gondii serology and/or PCR 2
  • Mycobacterium tuberculosis testing 2
  • Fungal testing 2

Seasonal and Exposure-Based Testing

  • Arbovirus and tick-borne disease testing in summer/fall presentations 2
  • Bartonella antibody (serum) with cat exposure, particularly if seizures and paucicellular CSF 2
  • Rabies testing with animal bite or bat exposure 2
  • Naegleria fowleri (CSF wet mount and PCR) with freshwater swimming or nasal irrigation history 2

Symptom-Specific Testing

  • Mycoplasma pneumoniae serology and throat PCR with respiratory symptoms (if positive, perform CSF PCR) 2
  • Rickettsia serology with elevated transaminases 2

Hepatic Encephalopathy-Specific Considerations

Ammonia Testing

Ammonia level should be measured if hepatic encephalopathy is suspected, but proper technique is critical: 1

  • Collect in EDTA-containing tube 1
  • Avoid venous stasis (no tourniquet) 4, 1
  • Place immediately on ice 4, 1
  • Transport to laboratory within 60-90 minutes at 4°C 4, 1

Critical caveat: Do not rely solely on ammonia levels for diagnosis or exclusion of hepatic encephalopathy—clinical context is paramount. 4, 1 A normal ammonia level should prompt reconsideration of the diagnosis. 1

Precipitant Identification

When hepatic encephalopathy is suspected, systematically evaluate for precipitants: 4

  • Diagnostic paracentesis in patients with ascites to exclude spontaneous bacterial peritonitis (this is frequently omitted—77% of eligible patients in one study did not receive this test) 5
  • Stool culture if diarrhea present 2
  • Review medications for sedatives, diuretics, or other precipitants 4

Neurophysiology and Imaging

Electroencephalography

EEG should be obtained to identify non-convulsive seizures and grade severity of encephalopathy. 2, 1 EEG may show diffuse slowing characteristic of metabolic encephalopathy and can detect epileptiform discharges in the absence of clinical seizure activity. 6, 7

Neuroimaging

Brain MRI is the preferred imaging modality and should be obtained in the initial evaluation to exclude structural lesions, subdural hematoma, stroke, or other focal pathology. 1 CT is acceptable if MRI unavailable but is less sensitive. 8

Neuroimaging is mandatory in: 4, 3

  • First episode of encephalopathy
  • Focal neurological findings
  • Patients with liver disease or alcohol abuse
  • Diagnostic uncertainty or failure to improve with treatment
  • Anticoagulated patients (to exclude subdural hematoma)

Critical Pitfalls to Avoid

Do not attribute encephalopathy to a single cause without excluding concurrent precipitants. 4 Infection (UTI, pneumonia), gastrointestinal bleeding, constipation, electrolyte disturbances, and medications frequently coexist. 4

Do not delay brain imaging while pursuing metabolic workup—22% of patients with suspected metabolic encephalopathy have alternative structural diagnoses. 3

Do not skip diagnostic paracentesis in cirrhotic patients with ascites—spontaneous bacterial peritonitis is a critical precipitant that is frequently missed. 5

Do not confuse alcohol withdrawal with hepatic encephalopathy in cirrhotic alcoholics—they require different treatments and can coexist. 4

Do not order ammonia levels in isolation or use them to guide treatment decisions—clinical diagnosis based on West Haven Criteria after excluding other causes is the standard approach. 4, 1

Adherence to Guidelines

A retrospective study found only 22% of hospitalized patients with hepatic encephalopathy received complete diagnostic workup within 24 hours, with blood cultures missing in 30%, urinalysis in 21%, and chest radiograph in 20%. 5 Paradoxically, serum ammonia (not endorsed by guidelines for routine workup) was ordered in 95% of patients. 5 This underscores the need for systematic adherence to evidence-based diagnostic algorithms.

References

Guideline

Laboratory Workup for Metabolic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Acute Encephalopathy in Elderly Post-CABG Patient

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Metabolic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2013

Research

Clinical and electroencephalographic correlates of acute encephalopathy.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2013

Related Questions

What is the management approach for a patient with diffuse slow waves on EEG indicative of encephalopathy?
How to manage a patient with clinically diagnosed metabolic encephalopathy, potentially with underlying liver disease, seizures, and electrolyte imbalances?
What are the next steps in diagnosis and management for an elderly female patient with acute encephalopathy of unknown cause, suspected urosepsis or metabolic derangements, with a history of Coronary Artery Bypass Graft (CABG), Chronic Kidney Disease (CKD), hypertension, and diabetes, currently on antibiotics and anticoagulants?
What are the causes and management of encephalopathy?
What is the recommended PM&R (Physical Medicine and Rehabilitation) approach for managing encephalopathy?
What is the best treatment approach for a patient with severe hypernatremia (elevated sodium level) and a sodium level of 161 mmol/L?
What is the differential diagnosis for a 30-year-old patient with multiple painless lymphadenopathies (lymph node enlargements), anemia, and no fever (afebrile)?
What is the best approach for managing Posterior Reversible Encephalopathy Syndrome (PRES) in an adult patient with a history of hypertension and/or immunosuppression?
What is the recommended treatment for an uncomplicated boil in a healthy adult patient with no significant underlying medical conditions?
What is the best treatment approach for a patient experiencing a Crohn's flare?
Is there a role for administering albumin with furosemide (Lasix) in patients with nephrotic syndrome and significant hypoalbuminemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.